Lixte Biotech Hlds (LIXT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,106 | 2,913 | 4,088 | 5,353 | 6,562 |
| Other current assets | 78 | 78 | 131 | 147 | 147 |
| TOTAL | $5,235 | $3,095 | $4,331 | $5,561 | $6,820 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $5,235 | $3,095 | $4,331 | $5,561 | $6,820 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 221 | 367 | 224 | 231 | 307 |
| Other current liabilities | 91 | 36 | 26 | 165 | 101 |
| TOTAL | $312 | $403 | $250 | $396 | $408 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $312 | $403 | $250 | $396 | $408 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,249 | 2,249 | 1,666 | 1,666 | 1,665 |
| Common Shares | 0 | 0 | 2 | 0 | 2 |
| Retained earnings | -47,450 | -46,431 | -44,762 | -43,395 | -41,763 |
| TOTAL | $4,923 | $2,693 | $4,081 | $5,165 | $6,411 |
| Total Liabilities And Equity | $5,235 | $3,095 | $4,331 | $5,561 | $6,819 |